Related references
Note: Only part of the references are listed.Therapeutic potential of CAR T cell in malignancies: A scoping review
Ali Zarezadeh Mehrabadi et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Drug release study of the chitosan-based nanoparticles
Yedi Herdiana et al.
HELIYON (2022)
Chitosan Nanoparticles for Antiviral Drug Delivery: A Novel Route for COVID-19 Treatment
Abdel-Majed Safer et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)
Ionotropic Gelation of Chitosan Flat Structures and Potential Applications
Pasquale Sacco et al.
MOLECULES (2021)
CAR-T cell therapy: current limitations and potential strategies
Robert C. Sterner et al.
BLOOD CANCER JOURNAL (2021)
Metabolic Plasticity in Chemotherapy Resistance
Maria Andrea Desbats et al.
FRONTIERS IN ONCOLOGY (2020)
Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors
Ombretta Melaiu et al.
FRONTIERS IN IMMUNOLOGY (2020)
Preparation and Characterization of Chitosan Nanoparticles for Chemotherapy of Melanoma Through Enhancing Tumor Penetration
Hui Guo et al.
FRONTIERS IN PHARMACOLOGY (2020)
Assessment of Image-Guided Intratumoral Delivery of Immunotherapeutics in Patients With Cancer
Rahul A. Sheth et al.
JAMA NETWORK OPEN (2020)
Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
Yihan Yao et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
A review of cancer immunotherapy: from the past, to the present, to the future
K. Esfahani et al.
CURRENT ONCOLOGY (2020)
Enhancing tumor T cell infiltration to enable cancer immunotherapy
Jin Zhang et al.
IMMUNOTHERAPY (2019)
Chitosan nanoparticles induced the antitumor effect in hepatocellular carcinoma cells by regulating ROS-mediated mitochondrial damage and endoplasmic reticulum stress
Yibing Jiang et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
Cell wall fraction of Mycobacterium indicus pranii shows potential Th1 adjuvant activity
Mohd Saqib et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Study of the conformational behaviour of trehalose mycolates by FT-IR spectroscopy
F. Migliardo et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2019)
Delivery technologies for cancer immunotherapy
Rachel S. Riley et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Lymph Node Subcapsular Sinus Macrophages as the Frontline of Lymphatic Immune Defense
Dante Alexander Patrick Louie et al.
FRONTIERS IN IMMUNOLOGY (2019)
A Clinical Trial of the Intradermal TLR2 Agonist CADI-05 for BCG Recurrent and Unresponsive Non-Muscle Invasive Bladder Cancer
Michael A. O'Donnell et al.
BLADDER CANCER (2019)
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity
Sabine Hoves et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
A randomized trial of TLR-2 agonist CADI-05 targeting desmocollin-3 for advanced non-small-cell lung cancer
C. P. Belani et al.
ANNALS OF ONCOLOGY (2017)
VALIDATION OF THE SULFO-PHOSPHOVANILLIN (SPV) METHOD FOR THE DETERMINATION OF LIPID CONTENT IN OLEAGINOUS MICROORGANISMS
A. Anschau et al.
BRAZILIAN JOURNAL OF CHEMICAL ENGINEERING (2017)
Effect of net surface charge on physical properties of the cellulose nanoparticles and their efficacy for oral protein delivery
Yongbo Song et al.
CARBOHYDRATE POLYMERS (2015)
Carboxymethyl chitosan represses tumor angiogenesis in vitro and in vivo
Zhiwen Jiang et al.
CARBOHYDRATE POLYMERS (2015)
Mycobacterium indicus pranii induces dendritic cell activation, survival, and Th1/Th17 polarization potential in a TLR-dependent manner
Pawan Kumar et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Elvin Blanco et al.
NATURE BIOTECHNOLOGY (2015)
The Mycobacterial Cell Wall-Peptidoglycan and Arabinogalactan
Luke J. Alderwick et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
The importance of nanoparticle shape in cancer drug delivery
Nghia P. Truong et al.
EXPERT OPINION ON DRUG DELIVERY (2015)
Cytokines as biomarkers of nanoparticle immunotoxicity
Mahmoud Elsabahy et al.
CHEMICAL SOCIETY REVIEWS (2013)
Nanoparticle mediated co-delivery of paclitaxel and a TLR-4 agonist results in tumor regression and enhanced immune response in the tumor microenvironment of a mouse model
Aniruddha Roy et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Phase III Trial of Carboplatin and Paclitaxel With or Without Sorafenib in Metastatic Melanoma
Keith T. Flaherty et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Immunotherapeutic efficacy of Mycobacterium indicus pranii in eliciting anti-tumor T cell responses: Critical roles of IFNγ
Srabanti Rakshit et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Activation of Anti-Tumor Immune Response and Reduction of Regulatory T Cells with Mycobacterium indicus pranii (MIP) Therapy in Tumor Bearing Mice
Faiz Ahmad et al.
PLOS ONE (2011)
Combined Chemo-immunotherapy as a Prospective Strategy To Combat Cancer: A Nanoparticle Based Approach
Aniruddha Roy et al.
MOLECULAR PHARMACEUTICS (2010)
Bacteria in cancer therapy: a novel experimental strategy
S. Patyar et al.
JOURNAL OF BIOMEDICAL SCIENCE (2010)
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Frank Alexis et al.
MOLECULAR PHARMACEUTICS (2008)
An orally delivered small-molecule formulation with antiangiogenic and anticancer activity
Ofra Benny et al.
NATURE BIOTECHNOLOGY (2008)
Levels of CD40 expression on dendritic cells dictate tumour growth or regression
G. Murugaiyan et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma
K Hiraoka et al.
BRITISH JOURNAL OF CANCER (2006)
Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation
H Gelderblom et al.
EUROPEAN JOURNAL OF CANCER (2001)
Characteristics and biodistribution of cationic liposomes and their DNA complexes
H Ishiwata et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Share Paper
